XRHealth Form D (2026)

Summary

The SEC Form D for XRHealth, filed on 2026-10-23, reports $16,253,029 raised. The legal name on the form is XRHealth, Inc. The form does not name the purchasers. Filing: https://www.sec.gov/Archives/edgar/data/1892473/000189247326000009/0001892473-26-000009-index.htm

The form says the shares were issued as consideration in XRHealth's acquisition of PursueCare LLC and Harvest Bio LLC, to the sellers PAI Holding Company LLC and PAI Delaware Holding Company, Inc. A second clarification says 1,146,849 shares of common stock at $14.1719 a share, plus performance warrants for up to 705,622 shares at a $0.71 exercise price, contingent on a 24-month sales milestone, issued as an inducement and not sold separately. A same-day Form D, accession 0001892473-26-000010, reports $3,877,693 sold of $3,877,693 offered. The issue says that filing is not combined, and it is not used as a source. That other form says Series A-1 preferred was sold for cash and that shares went to Connecticut Innovations, Inc. for debt relief. Connecticut Innovations does not have a page. Earlier Form D filings in September 2026 are not combined. The related person is in Brookline. The issuer city is Needham and is not stored as a headquarters. Incorporated more than five years ago.

This page is not indexed by search engines yet because the filing does not name the purchasers.

Investors

Sources

Last verified: 2026-10-27

1. https://www.sec.gov/Archives/edgar/data/1892473/000189247326000009/0001892473-26-000009-index.htm
   Type: sec filing. Accessed 2026-10-27.
   SEC Form D for XRHealth, Inc. EDGAR filing date 2026-10-23. Signed 2026-10-23 by Eran Orr. First sale 2026-10-22. Total amount sold $16,253,029 of an offering amount of $16,253,029. 2 investors already invested. Issuer address city is Needham, Massachusetts. Jurisdiction on the form: Delaware. The form says the issuer was incorporated more than five years ago. The form does not name the purchasers or a round type. Street addresses and phone numbers are not published. The form's security types are equity and an option, warrant, or other right to acquire another security. The form says the shares were issued as consideration in XRHealth's acquisition of PursueCare LLC and Harvest Bio LLC, to the sellers PAI Holding Company LLC and PAI Delaware Holding Company, Inc. A second clarification says 1,146,849 shares of common stock at $14.1719 a share, plus performance warrants for up to 705,622 shares at a $0.71 exercise price, contingent on a 24-month sales milestone, issued as an inducement and not sold separately. A same-day Form D, accession 0001892473-26-000010, reports $3,877,693 sold of $3,877,693 offered. The issue says that filing is not combined, and it is not used as a source. That other form says Series A-1 preferred was sold for cash and that shares went to Connecticut Innovations, Inc. for debt relief. Connecticut Innovations does not have a page. Earlier Form D filings in September 2026 are not combined. The related person is in Brookline. The issuer city is Needham and is not stored as a headquarters. Incorporated more than five years ago.
2. https://buttondown.com/raisetrack/archive/raise-track-update-2026-10-26/
   Type: other verified public source. Accessed 2026-10-27.
   Raise Track Update for 2026-10-26, Section 3. Lists XRHealth in Massachusetts, industry Other Health Care, amount raised $16,253,029.